AMETEK's updated valuation work now points to a fair value of about US$284.72, compared with roughly US$278.33 in the prior framework. Recent analyst commentary around the Q3 2026 beat, organic order growth of 17%, and the closing of the US$5b Indicor acquisition helps explain why price targets are clustering higher, even as many firms keep more balanced ratings. Read on to see what is driving this evolving narrative and how you can track the next round of revisions.
Stay updated as the Fair Value for AMETEK shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on AMETEK.
What Wall Street Has Been Saying
🐂 Bullish Takeaways
-
RBC Capital lifted its price target on AMETEK to US$308 from US$291 after what it called a high quality Q3 beat and raise, pointing to 17% organic order growth and the closing of the US$5b Indicor T&M acquisition as key supports for the investment case.
-
RBC also highlighted 10% organic sales growth that it described as broad based across aerospace and defense, semiconductors, medtech, and power, which analysts there see as evidence of solid execution across several end markets.
-
Morgan Stanley increased its AMETEK target to US$275 from US$245 in October after updating and rolling forward estimates, which contributes to the cluster of targets in the mid to high US$200s range.
🐻 Bearish Takeaways
-
Baird recently trimmed its AMETEK target to US$272 from US$280 and kept a Neutral rating, even though it cited good guidance and what it views as solid visibility into 2027, which suggests some caution on valuation at current levels.
-
Citi raised its target twice in recent months, from US$261 to US$263 and then to US$270, but it continues to carry a Neutral stance, which signals a more balanced view on the stock despite the higher targets.
Do your thoughts align with the Bull or Bear Analysts? Perhaps you think there's more to the story. Head to the Simply Wall St Community to discover more perspectives!
We've flagged 1 risk for AMETEK. See which could impact your investment.
How This Changes the Fair Value For AMETEK
-
Fair value is now about US$284.72, compared with roughly US$278.33 in the previous framework.
-
Revenue growth assumptions are set at around 8.59%, compared with about 12.74% before.
-
Net profit margin is now modeled at about 21.85%, up from roughly 20.14%.
-
The future P/E multiple used in the analysis is roughly 36.99x, compared with about 36.46x previously.
-
The discount rate in the updated framework is about 9.61%, compared with 9.50% before.
Never Miss an Update: Follow The Narrative
Narratives link AMETEK's business story to a structured financial forecast and fair value view. They update as new earnings, acquisitions, and industry data come through so you can see how the thesis evolves over time.
Head over to the Simply Wall St Community and follow the Narrative on AMETEK to stay up to date on:
-
How AMETEK's exposure to AI driven semiconductors, data centers, defense, aerospace, and power infrastructure feeds into higher margin, recurring revenue streams.
-
The role of acquisitive growth, including the Indicor platform and targeted niche businesses, in supporting margins, cash conversion, and earnings.
-
Key risks such as reliance on premium P/E multiples, execution against revenue and margin assumptions, and potential pressure in slower growing parts of the portfolio.
This article is general in nature and was produced with the assistance of AI automation, based on data and analysis from Simply Wall St. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AME .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
